Replies to post #64005 on GrowLife Inc (fka PHOT)

[SIObserver]

Nickels and dimes at this point. It matters not. We all with a bundle of shares are going to reap the benefits thereof. One ups-man-ship is a non-issue at this point. I wish you great success and I hope you wish me and the other FI$X shareholders success as well as the PHOT shareholders.

Why fight when both are dependent upon the other for a significant portion of the initial pop up.

Fighting amongst shareholders in companies joined at the hip seems to me to be counterproductive but then what do I know? Go ahead go about destroying one of the largest partners you have. I'm just here for the bucks dudes and duddets...if you can.

SIO

PS, call me when you're in the unemployment line. My number is 000-000-0000.

[TITAN]

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=97686267

[lesgetrich]

I went back and reviewed the 8k and found a couple of interesting tidbits that have seemed to escape discussion. Note:

 In addition to functioning as a supplier, OGI was granted the global right to distribute all products and services sold or licensed by CEN anywhere in the world. The MEPS shall remain in effect for so longer as OGI or the Company is a CEN shareholder or five years, whichever is longer.

and "The Company" (PHOT in this quote)...

On January 24, 2014, the Company executed an Interest Purchase Agreement (“RXNB IPA”) whereby WP and AJOA sold to OGI 40% of the fully diluted outstanding equity of R.X.N.B., Inc., a Nevada corporation (“RXNB”). As discussed above, the Company has a 45% ownership interest in OGI, a joint venture with CANX, and there are conditions under which it may gain a majority interest in the joint venture. The Company is obligated to issue shares of common stock to the Sellers under the RXNB IPA (see below). Among other ventures, RXNB formulates, manufactures, and distributes prescription drugs and dietary supplements to pharmaceutical and/food grade standards.  RXNB also owns and operates a laboratory and testing unit within the scope of its business operations.  The pharmacy operations of RXNB supply approximately 50,000 patients per month, and directly or indirectly support the practices of over 2700 clinicians.  RXNB intellectual property includes technology for manufacturing and growing legal, medical grade cannabis in accordance with current good manufacturing practices (“cGNP”) to pharmaceutical standards.

In other words, OGI can obtain product from FITX to sell globally and it has immediate access to over 50,000 medical marijuana patients. Me thinks some of that product will also end up in legal US states :-)